Uncategorized
The New York Times By Christina Jewett and Ellen Gabler March 13, 2023 An agreement between attorneys general and major drug distributors increased scrutiny on medications for A.D.H.D., addiction, anxiety and pain. Nearly a year after a sweeping opioid settlement imposed new requirements on the companies that provide medications to pharmacies, patients across the United... read more
A Fraught New Frontier in Telehealth: Ketamine
The New York Times By Chris Hamby Feb. 20, 2023 Ketamine can be mind-altering, and getting it has become much easier. Many mental health patients call the drug lifesaving. But some complain of bladder ailments, inadequate oversight and addiction. Is this good medicine, or telehealth run amok? With loosened rules around remote prescriptions, a psychedelic-like... read more
Los Angeles Times By Denise Guerra, Samantha Masunaga Feb. 23, 2023 (Hanna Barczyk / For The Times) Faced with high levels of worker stress, anxiety and burnout as a result of the COVID-19 pandemic, many companies pledged that employee mental health would become a top priority. Firms promised manager training to ensure bosses were more... read more
The New York Times By Christina Caron Feb. 18, 2022 The symptoms of attention deficit hyperactivity disorder can push couples to their breaking point, but there is hope for those willing to seek help. When Chris Lawson began dating Alexandra Salamis, the woman who would eventually become his partner, he was “Mr. Super Attentive Dude,”... read more
The Washington Post By Steven Petrow September 5, 2022 Interest in and use of the drug is growing, but much is unknown A few weeks ago, I mentioned to a friend that I was interested in learning more about psychedelics, especially how they might help me with depression and anxiety. That’s a broad category of... read more
The New York Times By Dana G. Smith Feb. 10, 2023 While drugs like ketamine and psilocybin are largely considered safe, here’s what to know about who should be cautious. When Dr. Charles Nemeroff first met his patient, the 32-year-old woman had already been to see several psychiatrists. Initially, the woman, whose identity has been... read more
Los Angeles Times By Lindsey Tanner Feb. 13, 2023 The pandemic took a harsh toll on U.S. teen girls’ mental health, with almost 60% reporting feelings of persistent sadness or hopelessness, according to a government survey released Monday that bolsters earlier data. Sexual violence, suicidal thoughts, suicidal behavior and other mental health woes affected many teens regardless... read more
I tried ketamine to treat my depression. It was terrifying.
The Washington Post By Steven Petrow February 12, 2023 The psychedelic therapy is said to help many people, but some like me have scary experiences My ears perked up in recent months when I began to hear the buzz about ketamine, the anesthetic and hallucinogenic drug that has found a new market as an antidepressant. Numerous... read more
Los Angeles Times By Keri Blakinger, Connor Sheets Feb. 2, 2023 CABO SAN LUCAS, Mexico — If you walk down the right side street, the offers are plentiful, even in broad daylight. Young men in plain T-shirts draw near and call out their wares: Pills. Cocaine. Guns. But if you wave them away and go just... read more
What We Know About Treating Extreme Grief With Psychedelics
The New York Times By Dana G. Smith Jan. 10, 2023 In his new memoir, Prince Harry talks about taking psychedelics to deal with the ongoing pain over the death of his mother. Here’s what we know and don’t know about their effectiveness. Prince Harry and Meghan Markle have been remarkably transparent about their psychological... read more